Erenumab was the first drug of a new drug class for the prophylaxis of migraine to enter the German market in November 2018. In an early benefit ... read more
Erenumab in migraine: Indication of considerable added benefit for certain patients
Erenumab in migraine: Indication of considerable added benefit for certain patients